NCT06137729View on ClinicalTrials.gov

A Study to Learn How the Study Medicine PF-07899895 Are Tolerated and Act in the Body of Healthy Adults

PHASE1RecruitingINTERVENTIONAL

Enrollment

53

Participants

Timeline

Start Date

November 17, 2023

Primary Completion Date

February 19, 2026

Study Completion Date

February 19, 2026

Conditions

Healthy

Interventions

DRUG

PF-07899895

Participants will receive oral ascending doses.

DRUG

Placebo

Participants will receive matching placebo.

Trial Locations (1)

B-1070

RECRUITING

Pfizer Clinical Research Unit - Brussels, Brussels

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY

NCT06137729 - A Study to Learn How the Study Medicine PF-07899895 Are Tolerated and Act in the Body of Healthy Adults | Biotech Hunter | Biotech Hunter